Servuer Pharmaceutical Co., Ltd. is committed to producing the highest quality pharmaceuticals and active pharmaceutical services to the pharmaceutical industry to provide the highest standards. At present, the factory produced a total of seven products, namely: encouraging ®, Acertil ®, gliclazide sustained release tablets ® the trimetazidine ®。
Tianjin Servuer developed an antithrombotic, inhibit platelet aggregation, inhibition of thrombosis, anti-vasoconstriction, anti-atherosclerosis drugs, now all clinical testing has been completed, he tried to enter the market. However, in the market such a wide variety of medicines, all the competition, how to make the new products performed well enough to go around the market, a slice has become the biggest problem faced by the Servier. Prophet received this project to develop a clear objective, that is, to find their unique selling point, the formation of the distinctive features of the brand, create a unique brand name.
After investigation, the Chinese market, anti-clotting drugs foreign brands dominate the world, the efficacy advantage by virtue of its quality, consumer trust and recognition of foreign brands is generally higher than the domestic brands, Servier brand who would like to win the market must also highlight their own international quality, international quality, domestic prices, this is the Wewin for the new Servier drugs derives from the selling point, and supported by the international name "Nuoshi An" reflects the product quality and safety and reliability effect.